Migraine
Conditions
Keywords
migraine, headache, rhinosinusitis, COVID-19
Brief summary
A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.
Interventions
None listed
Sponsors
Wroclaw Medical University
Swiat Zdrowia
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* consent to participate in the study
Exclusion criteria
* responses missing in questionnaire
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Headache phenotype | in the preceding year | Classification of reported headache according to International Classification of Headache Disorders |
| Migraine burden | in the preceding year | Consequences of the disease measured by the Migraine Disability Assessment Test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Monthly headache days | in the preceding month | Number of days per month |
| Time from last headache professional consultation | in the preceding 10 years | Number of months |
| Migraine diagnosed by headache professional | in the preceding 10 years | yes/no |
| Age at diagnosis | from the onset of headache (time frame up to 99 years) | years |
| Comoribidities | in the preceding year | Disease according to International Classsification of Disease 10 |
| Type of previous headache professional consultation | in the preceding 10 years | Name of headache profession/speciality |
| Number of consultations in the last year | in the last 12 months | Number 0-100 |
| Number of consultations in the last year because of headaches | in the last 12 months | Number 0-100 |
| Number of days spent in hospital in the last year because of headaches | in the last 12 months | Number 0-100 |
| Acute treatment used | in the preceding 10 years | Name of abortive medication |
| Preventive treatment used | in the preceding 10 years | Name of abortive medication |
| Acute treatment frequency | in the last 3 months | Number of days per month |
| Preventive treatment frequency | in the last 12 months | Number of months form the last dose |
| Preventive treatment effectiveness | in the last 12 months | Likert scale |
| Employment | in the last 12 months | Type of employment |
| Time spent at work | in the last 12 months | Number of hours per week |
| Work absence due to headache | in the last month | Number of days per month |
| Presenteeism | in the last month | Number of days per month |
| PHQ-9 Patient Health Questionnaire | in the last 2 weeks | Number |
| Sinus headache | in the last 3 months | Number of days |
| Sinonasal symptoms accompanying headache | in the last 12 months | Type of symptoms |
| Sinonasal symptoms not associated with headache | in the last 12 months | Type of symptom |
| COVID-19 association with headache | in the last 2 years | Likert scale |
| COVID-19 vaccine association with headache | in the last year | Likert scale |
Countries
Poland
Outcome results
None listed